Teleflex Incorporated (TFX) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Teleflex Incorporated  (NYSE: TFX)

Select the Financial Report: Select the Period:


Description of Teleflex Incorporated's Business Segments


Teleflex Incorporated is a prominent global provider of innovative medical devices, dedicated to addressing a wide range of clinical challenges. The companys operations are structured into three major business segments: Interventional, Surgical, and Anesthesia and Respiratory. Each segment focuses on specific areas of medical care and intervention, offering a diverse array of products and services tailored to meet the needs of healthcare providers and patients.

1. Interventional Segment

The Interventional Segment specializes in creating and marketing devices designed for various interventional procedures. This often includes the use of catheters and devices essential for vascular access and diagnostic procedures. Key product categories within this segment are:

- Arrow Vascular Access: This line provides a variety of vascular access catheters designed for different clinical applications, including:

- Peripherally Inserted Central Catheters (PICCs): Used for long-term vascular access for medication administration and other therapies.

- Midline Catheters: Best suited for shorter-term vascular access, typically used in cases requiring medication or fluid administration over a few days.

- Dialysis Catheters: Specifically designed for patients who need renal dialysis, allowing for efficient blood access during treatment.

- Arrow Diagnostic and Therapeutic Catheters: These catheters cater to a broad spectrum of diagnostic and therapeutic applications, suitable for use in varied clinical settings.

- Arrow Advanced Drainage Systems: This encompasses specialized drainage systems for managing fluid accumulation, including:

- Pleural Drainage Systems: Designed to remove fluid from the pleural cavity, assisting in conditions like pleural effusion.

- Peritoneal Drainage Systems: Intended for the management of abdominal fluid collections.

- Vascular Franchise: Features advanced tools aimed at interventional radiologists:

- Guidewires and Microcatheters: Critical for navigating complex vascular structures during interventional procedures.

- Embolization Coils and Embolic Agents: Employed to occlude blood vessels effectively in various treatments.

Surgical Segment

The Surgical Segment focuses on providing precision surgical instruments and devices that enhance the efficacy of surgical procedures. Key product lines include:

- Weck Surgical Instruments: This extensive lineup includes:

- Scalpels and Blades: Essential for making precise incisions during surgical procedures.

- Surgical Scissors and Forceps: Used for a variety of tissue handling and manipulation tasks.

- Pilling Surgical Instruments: Offers a wide selection of surgical tools, such as:

- Dissectors: Employed for separating tissues to enhance visibility and access during surgery.

- Specialized Scissors and Forceps: Designed for specific surgical needs across various medical specialties.

- LMA Anesthesia Products: A crucial line in anesthesia management, including:

- Laryngeal Mask Airways (LMAs): Vital for maintaining airway patency during anesthesia administration, facilitating smoother induction and maintenance of anesthesia.

Anesthesia and Respiratory Segment

Within the Anesthesia and Respiratory Segment, Teleflex manufactures and markets an extensive range of products aimed at enhancing anesthesia delivery and respiratory care. Major product categories include:

- Hudson RCI: This product line is focused on supporting respiratory care, featuring:

- Breathing Circuits: Designed for providing ventilatory support, ensuring effective delivery of air to patients.

- Humidifiers and Chambers: These products improve air quality and provide comfort for patients requiring respiratory interventions.

- Rusch: This range encompasses vital tools for airway management, including:

- Endotracheal Tubes: Crucial for securing the airway during surgeries and in critical care environments.

- Tracheostomy Tubes and Laryngeal Mask Airways (LMAs): These are utilized in various airway management scenarios, ensuring effective ventilation.

- Arrow Pain Management: This product lineup addresses the needs for pain management, featuring:

- Peripheral Nerve Catheters: Used for delivering regional anesthesia, helping to manage pain effectively during and post-surgery.

- Nerve Blocks and Epidural Catheters: Essential for providing relief from postoperative pain and during labor.

Conclusion

Teleflex Incorporated offers a comprehensive and diverse array of products and services aimed at various medical specialties, including interventional radiology, surgical procedures, anesthesiology, and respiratory care. Known for its innovative solutions and commitment to quality, Teleflex focuses heavily on enhancing patient safety and clinical outcomes. The companys ongoing investment in research and development highlights its dedication to expanding its product portfolio and improving healthcare solutions, solidifying its position as a leader in the medical device industry.


Composition of Teleflex Incorporated Revenues by Segments

 
Vascular    43.26 % of total Revenue
Interventional    37.39 % of total Revenue
Surgical    19.51 % of total Revenue
segments    100.15 % of total Revenue
Americas    60.77 % of total Revenue
EMEA    26.79 % of total Revenue
Asia    12.59 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Vascular 236.81 43.26 %
Interventional 204.66 37.39 %
Surgical 106.79 19.51 %
segments 548.26 100.15 %
Americas 332.65 60.77 %
EMEA 146.68 26.79 %
Asia 68.93 12.59 %
Total 547.43 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Vascular 8.07 % -
Interventional 104.35 % -
Surgical 12.44 % -
segments 32.35 % -
Americas 14.82 % -
EMEA 77.49 % -
Asia 64.54 % -
Total -21.85 % -72.52 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -8.15 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Teleflex Incorporated Divisions, Sales by Country

 


Twelve months ended 2025
TFX s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 1,991.75 100 %


Twelve months ended 2025
TFX s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -905.64 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Interventional - -
Surgical - -
Americas - -
EMEA - -
Asia - -
Total -34.63 % -
Vascular access - -
Anesthesia - -
Interventional urology - -
OEM - -
Other - -
Revenues From External Customers And Long Lived Assets FromExternalCustomersAndLongLivedAssetsLineItems - -
UNITED STATES - -
Europe - -
Asia Pacific - -
All other - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.